4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-006880
EVP, Global Sales & Marketing sold 29,133 shares at an average $5.72 ($166,517)
- EVP, Global Sales & Marketing acquired 29,133 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-01 | Option exercise | +2,468 | $0.98 | $2,426 | 2,468 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-01 | Option exercise | +15,090 | $2.14 | $32,323 | 17,558 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-01 | Sale | −17,558 | $5.68 | $99,729 | 0 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-02 | Option exercise | +11,575 | $2.14 | $24,794 | 11,575 | D |
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-02 | Sale | −11,575 | $5.77 | $66,788 | 0 | D |
| Derivatives | |||||||
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-01 | Option exercise · Employee Stock Option (right to buy) | −2,468 | 0 | D | ||
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-01 | Option exercise · Employee Stock Option (right to buy) | −15,090 | 83,710 | D | ||
| Ross Thomas M. EVP, Global Sales & Marketing | 2023-02-02 | Option exercise · Employee Stock Option (right to buy) | −11,575 | 72,135 | D | ||
| Open-market sales · 29,133 sh · avg $5.72 · $166,517 | |||||||
Loading xslF345X03/doc4.xml…